Rossby Financial’s Rein Therapeutics RNTX Stock Holding History

Rossby Financial’s Portfolio RNTX Stock Details RNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$73.5K	Buy	+91,400	New	+$74.9K	0.01%	790

Other funds holding RNTX

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

BIOS Capital Management Fort Worth, Texas $34.2M AUM 13.29% 1-Year Est. Return

Prosight Management Dallas, Texas $515M AUM 2.95% 1-Year Est. Return

Senvest Management New York $3.45B AUM 44.97% 1-Year Est. Return

Bleichroeder LP New York $1.02B AUM 33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $798M AUM 22.92% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Texas Capital Bank Wealth Management Services Dallas, Texas $1.94B AUM 19.18% 1-Year Est. Return

Rossby Financial's RNTX Position: Q3 2026 in Review

Rossby Financial opened a new position in Rein Therapeutics (RNTX) in Q3 2026: 91,400 shares worth $73.5K. The stake represents 0.01% of the portfolio and ranks #790 among its holdings.

47 funds tracked by Wall St. Rank hold RNTX as of Q3 2026.

Rossby Financial held 91,400 shares of Rein Therapeutics worth $73.5K as of Q3 2026.
Rein Therapeutics was a new Rossby Financial position in Q3 2026.
Rein Therapeutics made up 0.01% of Rossby Financial's portfolio in Q3 2026, its #790 holding.
47 funds tracked by Wall St. Rank held Rein Therapeutics as of Q3 2026.

Based on Rossby Financial's 13F filing for Q3 2026, filed 5 Nov 2026.